{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006412",
      "entity_text" : "translation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ08208",
      "entity_text" : "CD44v6-targeting peptide",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Moreover, the availability of a human CD44v6 targeting peptide enables clinical translation of these results in de near future.",
  "reading_complete" : "2020-08-02T18:07:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:06:12Z",
  "trigger" : "enables",
  "evidence" : [ "CD44v6-targeting peptide enables clinical translation" ],
  "pmc_id" : "5327362",
  "score" : 0
}